Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dacarbazine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01693068
What this trial is testing

Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma

Who this might be right for
N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma
EMD Serono 194
Testing effectiveness (Phase 2)Study completedNCT04225390
What this trial is testing

Preconditioning of Tumor, Tumor Microenvironment and the Immune System to Immunotherapy

Who this might be right for
Immunotherapy
University of Erlangen-Nürnberg Medical School 38
Large-scale testing (Phase 3)Study completedNCT01006980
What this trial is testing

Vemurafenib (RO5185426) in Comparison With Dacarbazine in Previously Untreated Patients With Metastatic Melanoma (BRIM 3)

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 675
Testing effectiveness (Phase 2)Study completedNCT00837148
What this trial is testing

Sorafenib and Dacarbazine in Soft Tissue Sarcoma

Who this might be right for
SarcomaSynovial SarcomaLeiomyosarcoma+1 more
Memorial Sloan Kettering Cancer Center 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT03233347
What this trial is testing

Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma

Who this might be right for
Ann Arbor Stage I Hodgkin LymphomaAnn Arbor Stage IA Hodgkin LymphomaAnn Arbor Stage IB Hodgkin Lymphoma+4 more
Academic and Community Cancer Research United 83
Large-scale testing (Phase 3)WithdrawnNCT03342300
What this trial is testing

Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma

Who this might be right for
Progression-free SurvivalOverall SurvivalToxicity
Peking University People's Hospital
Testing effectiveness (Phase 2)Study completedNCT01845675
What this trial is testing

Chemotherapy Plus Endostatin in Advanced Pancreatic Neuroendocrine Tumor

Who this might be right for
Advanced Well-differentiated Pancreatic Neuroendocrine Tumor
Peking Union Medical College Hospital 14
Not applicableUnknownNCT04893356
What this trial is testing

Impact of O6-methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and MGMT Expression on Dacarbazine Treated Sarcoma Patients (MGMT)

Who this might be right for
Sarcoma
National Cancer Institute, Naples 75
Testing effectiveness (Phase 2)Study completedNCT03070392
What this trial is testing

Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma

Who this might be right for
Uveal Melanoma
Immunocore Ltd 378